Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 05/20/21 | 8-K | Form 8-K: Current report filing | 4 | |
| 05/14/21 | 8-K | Form 8-K: Current report filing | 3 | |
| 05/13/21 | DEF 14A | Form DEF 14A: Definitive proxy statements | 23 | |
| 05/10/21 | 10-Q | Form 10-Q: Quarterly report pursuant to Section 13 or 15(d) |
|
18 |
| 05/10/21 | 8-K | Form 8-K: Current report filing | 5 | |
| 05/03/21 | PRE 14A | Form PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition | 23 | |
| 05/03/21 | 8-K | Form 8-K: Current report filing | 2 | |
| 04/30/21 | 10-K/A | Form 10-K/A: Annual report pursuant to Section 13 and 15(d) | 11 | |
| 04/27/21 | 8-K | Form 8-K: Current report filing | 3 | |
| 04/16/21 | 25-NSE | Form 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | 2 |